Skip to main content
. Author manuscript; available in PMC: 2019 Sep 29.
Published in final edited form as: Bioconjug Chem. 2019 Jan 29;30(2):366–383. doi: 10.1021/acs.bioconjchem.8b00761

Figure 3.

Figure 3.

Strategies for the delivery of ASO and/or siRNA.57 A: Covalent conjugation between the agent and the oligonucleotide. B: Examples of stable and cleavable linkages. C: Formation of a complex between a biomolecule or a polymer and the oligonucleotide via electrostatic interactions and/or the hydrophobic effect. D: Formation of liposomal supramolecular structure with targeting or transfecting agent (PEG, peptide, CPP, protein, lipid glycoconjugate, etc.).